Zobrazeno 1 - 10
of 70
pro vyhledávání: '"Dao-zhen Xu"'
Autor:
Chenliang Zhou, Chaofan Li, Guo-Zhong Gong, Shuang Wang, Ji-Ming Zhang, Dao-Zhen Xu, Li-Min Guo, Hong Ren, Min Xu, Qing Xie, Chen Pan, Jie Xu, Zhongyu Hu, Shuang Geng, Xian Zhou, Xianzheng Wang, Xiaoyu Zhou, Haili Mi, Gan Zhao, Wencong Yu, Yu-Mei Wen, Lihua Huang, Xuan-Yi Wang, Bin Wang
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 13, Iss 9, Pp 1989-1996 (2017)
An HBsAg-HBIG therapeutic vaccine (Yeast-derived Immune Complexes, YIC) for chronic hepatitis B (CHB) patients has undergone a series of clinical trials. The HBeAg sero-conversion rate of YIC varied from 21.9% to 14% depending on the immunization pro
Externí odkaz:
https://doaj.org/article/1080a3936d2c483b8f68206e5e8e5c9e
Autor:
Dao-Zhen Xu, Kai Zhao, Li-Min Guo, Lan-Juan Li, Qing Xie, Hong Ren, Ji-Ming Zhang, Min Xu, Hui-Fen Wang, Wen-Xiang Huang, Xue-Fan Bai, Jun-Qi Niu, Pei Liu, Xin-Yue Chen, Xin-Liang Shen, Zheng-Hong Yuan, Xuan-Yi Wang, Yu-Mei Wen
Publikováno v:
PLoS ONE, Vol 3, Iss 7, p e2565 (2008)
BACKGROUND: The safety of the immune complexes composed of yeast-derived hepatitis B surface antigen (HBsAg) and antibodies (abbreviated as YIC) among healthy adults and chronic hepatitis B patients has been proved in phase I and phase IIa trial. A l
Externí odkaz:
https://doaj.org/article/ec08b343e7404b2494439d4e745f1983
Autor:
Dao-Zhen Xu, Kai Zhao, Li-Min Guo, Lan-Juan Li, Qin Xie, Hong Ren, Ji-Ming Zhang, Min Xu, Hui-Fen Wang, Wen-Xiang Huang, Xue-Fan Bai, Jun-Qi Niu, Pei Liu, Xin-Yue Chen, Xin-Liang Shen, Zheng-Hong Yuan, Xuan-Yi Wang, Yu-Mei Wen
Publikováno v:
PLoS ONE, Vol 3, Iss 8 (2008)
Externí odkaz:
https://doaj.org/article/bbd486963f64419c8a533560af785062
Autor:
Shijun Chen, Hong Tang, Richard Guan, Jifang Sheng, Huang Zhenfei, Jiming Zhang, Guiqiang Wang, Xiaoling Fan, Wen-Hsiung Chang, Yuxiu Yang, Zhiliang Gao, Boping Zhou, Jinlin Hou, Qing Xie, Duande Luo, Yuming Wang, Dao-Zhen Xu, Tzong-Hsi Lee, Chen Pan, Wenxiang Huang, Rosmawati Mohamed, Mobin Wan, Zhang Ye, Lai Wei, Jun Cheng, Guofeng Chen, Qin Ning, Hong Ren, Huiguo Ding
Publikováno v:
Journal of Clinical Virology. 61(4):509-516
BackgroundIn mainland China, peginterferon (PEG-IFN) alfa-2b 1.0μg/kg/wk for 24 weeks is the approved treatment for HBeAg-positive chronic hepatitis B.ObjectiveThis multicenter, randomized trial evaluated the safety and efficacy of regimens utilizin
Autor:
Dao-Zhen, Xu, Xuan-Yi, Wang, Xin-Liang, Shen, Guo-Zhong, Gong, Hong, Ren, Li-Min, Guo, Ai-Min, Sun, Min, Xu, Lan-Juan, Li, Xin-Hui, Guo, Zhen, Zhen, Hui-Fen, Wang, Huan-Yu, Gong, Cheng, Xu, Nan, Jiang, Chen, Pan, Zuo-Jiong, Gong, Ji-Ming, Zhang, Jia, Shang, Jie, Xu, Qing, Xie, Tie-Feng, Wu, Wen-Xiang, Huang, Yong-Guo, Li, Jing, Xu, Zheng-Hong, Yuan, Bin, Wang, Kai, Zhao, Yu-Mei, Wen, Pu, Shan
Publikováno v:
Journal of Hepatology. 59:450-456
Background & Aims Even though various experimental therapeutic approaches for chronic hepatitis B infection have been reported, few of them have been verified by clinical trials. We have developed an antigen-antibody (HBsAg-HBIG) immunogenic complex
Publikováno v:
Advanced Materials Research. :826-829
The stratified water-oil two—phase flow was modeled using VOF method in horizontal pipe and surface tension was taken into consideration using CSF model. It was found that the surface tension had great impact on the small density difference two-pha
Autor:
Ming-Hui, Li, Lei-Ping, Hu, Lu, Zhang, Yao, Lu, Ge, Shen, Shu-Ling, Wu, Min, Chang, Cai-Qin, Mu, Yun-Zhong, Wu, Min, Yang, Shu-Jing, Song, Shu-Feng, Zhang, Wen-Hao, Hua, Yao, Xie, Jun, Cheng, Dao-Zhen, Xu
Publikováno v:
Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology. 23(11)
To investigate the efficacy and related factors of pegylated-interferon alpha-2a (PEG-IFN-2a) treatment in patients with hepatitis B e antigen (HBeAg)-positive chronic hepatitis B (CHB) who achieved partial viral response with nucleoside analogue (NA
Publikováno v:
Vaccine. 23:2658-2664
A therapeutic vaccine for viral hepatitis B composed of yeast-derived recombinant HBsAg complexed to human anti-HBs immunoglobulin (yeast-derived-immunogenic complex, YIC) with alum as the adjuvant was evaluated for safety. In stage 1, 22 healthy Chi
Autor:
Xia Guo, Hong-yu Zhang, Min-min Wang, Dao-zhen Xu, Li-min Guo, Jian-ping Zhang, Wei-yan Zhang, Lian-he Lu, Feng-xia Sun, Bao-shun Li, Ling-hang Wang, Xiao-dong Liu, Zhong-ping He, Jing-yuan Liu, Yun Yao, Hao Han
Publikováno v:
Liver International. 23:16-20
Background: Molecular Adsorbents Recirculating System (MARS) is a new promising artificial liver support therapy, the aim of this study was to assess the effectiveness of MARS to remove nitrous oxide (NO) and cytokines insevere liver failure patients
Autor:
Jun-Mei, Zhao, Lu, Zhang, Qing-Wei, Du, Cai-Qin, Mu, Yv-Lian, Ren, Lei-Ping, Hu, Ge, Shen, Li-Wei, Zhuang, Yao, Lu, Guo-Hua, Qiu, Qing-Feng, Sun, Yun-Zhong, Wu, Min, Yang, Ming-Hui, Li, Yao, Xie, Jun, Cheng, Dao-Zhen, Xu
Publikováno v:
Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology. 27(5)
A retrospective study was conducted to investigate the clinical features and prognostic factors of 73 cases of severe hepatitis.To summarize clinical features of 73 cases of severe hepatitis, grouping by etiology and pathogenesis. A retrospective ana